热门资讯> 正文
MaxCyte任命Parmeet Ahuja为首席财务官
2026-03-23 20:27
- MaxCyte (MXCT) said on Monday that it appointed Parmeet Ahuja as CFO, effective March 30, 2026, succeeding Douglas Swirsky, who is stepping down as previously announced.
- Ahuja brings over 20 years of finance leadership experience and most recently served as vice president of investor relations at Agilent Technologies.
- Shares +1.69%.
More on MaxCyte
- Quant snapshot: AAR, Noah Holdings lead strong buys as Blaize, Fractyl Health lag
- MaxCyte sees Q4 core revenue between $6.6M and $6.7M
- Seeking Alpha’s Quant Rating on MaxCyte
- Historical earnings data for MaxCyte
- Financial information for MaxCyte
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。